Christoph Rader, PhD

Associate Professor
Department of Immunology and Microbiology
Florida Campus

Scripps Research Joint Appointments

Associate Dean, TSRI Graduate Program
Faculty, Graduate Program

Research Focus

We develop and apply technologies for antibody drug and target discovery in cancer.


Ph.D., Biochemistry and Molecular Biology, University of Zurich (Switzerland), 1995
M.S., Biochemistry and Molecular Biology (dipl. biochem.), University of Zurich (Switzerland), 1991
B.S., Biochemistry and Chemistry (cand. dipl. biochem.), University of Bayreuth (Germany), 1988

Professional Experience

2012-present, Associate Professor with Tenure, Department of Immunology and Microbiology, The Scripps Research Institute (Jupiter, FL)
2003-2012, Senior Scientist and Head of the Antibody Technology Section, Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (Bethesda, MD)
1999-2003, Assistant Professor, Department of Molecular Biology, The Scripps Research Institute (La Jolla, CA)
1996-1999, Postdoc, Department of Molecular Biology, The Scripps Research Institute (La Jolla, CA)

Awards & Professional Activities

2013, Mentorship Award from the Scripps Florida Graduate Students and Postdocs (Jupiter, FL)
2011, Federal Technology Transfer Award, NCI, NIH (Bethesda, MD)
2007, NCI Director’s Intramural Innovation Award for Principal Investigators (Bethesda, MD)
2000, Investigator Award from the Cancer Research Institute (New York, NY)

NIH-funded Principal Investigator since 2002 (4 x R01, 1 x R21, 1 x R43, 1 x U01, 1 x UL2, 2 x ZIA)

Industry-funded Principal Investigator since 2013

NIH Study Section Reviewer since 2009 (F30, F31, F32, R41, R42, R43, R44, UC4)

Biotech and Pharma Consultant since 2000

Selected References

See Laboratory Website for a complete list of publications and patents.


Google Scholar



Two-pronged Antibodies Draw Immune Killers Directly to Cancer Cells

Cancer Researchers Awarded $2.875 Million to Eradicate Common Form of Leukemia

"Double Decker" Antibody Technology Fights Cancer

A Winning Combination?

Scripps Florida Scientists Develop New Drug Delivery Method for Cancer Therapy

Scripps Florida Collaboration Awarded $3.3 Million to Develop Next-Generation Breast Cancer Therapies

Scripps Florida Scientists Discover New Natural Source of Potent Anti-Cancer Drugs

Grant Supports Development of New Breed of Cancer Treatments

Scripps Florida Mentorship Award Honors Laura Niedernhofer and Christoph Rader

Christoph Rader and William Roush Awarded $1.4 Million Leukemia Research Grant

Christoph Rader Receives Lymphoma Research Grant

Scripps Research Appoints Cancer Biologist